Recombinant erythropoietin biosimilar (Elea)
重组人促红素生物类似药 (Elea)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant erythropoietin biosimilar (Elea)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2009/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesElea
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A